Cite
APA Citation
Lewis, J. D., Allez, M., Irving, P. M., Hoops, T., Izanec, J. L., Ma, T., Ding, Z., Muser, E., Gasink, C., Panaccione, R., Loftus, E. V., Danese, S., & Sands, B. E. (n.d.). s851 Health-Related Quality of Life With Ustekinumab vs Adalimumab for Induction and Maintenance Therapy in Biologic-Naïve Patients With Moderate-To-Severe Crohn's Disease: PROMIS-29 in the SEAVUE Study. American journal of gastroenterology, 116, S395. http://access.bl.uk/ark:/81055/vdc_100144524038.0x000031